Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany’s Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis

Deal Bolsters Curaleaf Presence and Cements Strategic Advantage in Europe’s Largest Market as Germany Readies for Adult Use MASSACHUSETTS: Curaleaf Holdings, Inc., a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International Holdings Limited, the company’s European holding company, has signed a definitive agreement to acquire a 55% stake in Four 20 Pharma GmbH, Read the full article...
http://dlvr.it/SWPPtb